View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 25, 2022
15 min read
Save

‘Poorly understood’ and rife with mimics: Rheum-neuro diseases require a team approach

‘Poorly understood’ and rife with mimics: Rheum-neuro diseases require a team approach

For all the multitudes of diseases and diversity of organ systems rheumatologists are adept at managing and analyzing, the brain, spinal cord and related neurological conditions are often not among them.

SPONSORED CONTENT
October 25, 2022
4 min watch
Save

VIDEO: Gene therapy potential treatment target for Duchenne muscular dystrophy

VIDEO: Gene therapy potential treatment target for Duchenne muscular dystrophy

CHICAGO – Jeffrey Chamberlain, PhD, professor of neurology at the University of Washington, discussed types of gene therapy as a possible treatment for muscular dystrophy at ANA 2022.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
October 25, 2022
2 min read
Save

Behavioral impulsivity in Parkinson’s disease may be linked to limbic-motor connections

Behavioral impulsivity in Parkinson’s disease may be linked to limbic-motor connections

CHICAGO — Behavioral impulsivity in Parkinson’s disease may be linked to several factors, including connections between the limbic system and motor function, per a presenter at the American Neurological Association annual meeting.

SPONSORED CONTENT
October 24, 2022
4 min watch
Save

VIDEO: Limbic system abnormalities play important role in functional movement disorders

VIDEO: Limbic system abnormalities play important role in functional movement disorders

CHICAGO – Mark Hallett, MD, chief of the motor control section at NINDS, discussed the pathology and etiology of functional neurological movement disorders at ANA 2022.

SPONSORED CONTENT
October 24, 2022
5 min watch
Save

VIDEO: Neurological long COVID-19: ‘It’s time’ to approach therapeutics

VIDEO: Neurological long COVID-19: ‘It’s time’ to approach therapeutics

CHICAGO – Jennifer A. Frontera, MD, professor of neurology at NYU School of Medicine, discussed possible therapeutic strategies for those with long COVID who are experiencing neurological symptoms at ANA 2022.

SPONSORED CONTENT
October 24, 2022
2 min read
Save

Pathology of COVID-19 affects CNS with longer symptom course

Pathology of COVID-19 affects CNS with longer symptom course

CHICAGO — The neurological pathology of COVID-19 becomes more complex as symptoms persist and tends to affect the central nervous system more prominently, according to an expert at the American Neurological Association annual meeting.

SPONSORED CONTENT
October 24, 2022
2 min read
Save

Dementia in older population linked to concurrent neuropathologies

Dementia in older population linked to concurrent neuropathologies

CHICAGO — Alzheimer’s disease-related dementia among older adults is linked to a combination of neurodegenerative and vascular pathologies, according to a presenter at the 2022 American Neurological Association annual meeting.

SPONSORED CONTENT
October 23, 2022
3 min watch
Save

VIDEO: Expert provides pearls for treatment of neurological infections

VIDEO: Expert provides pearls for treatment of neurological infections

CHICAGO – Felicia Chow, MD, MAS, a neuro-infectious specialist at the University of California, San Francisco, discussed the care and approach to neurological infections during a panel at ANA 2022.

SPONSORED CONTENT
October 23, 2022
2 min watch
Save

VIDEO: Expert says Parkinson’s disease is preventable, can be eradicated

VIDEO: Expert says Parkinson’s disease is preventable, can be eradicated

CHICAGO – Ray Dorsey, MD, MBA, neurology professor at the University of Rochester, discusses a presentation he gave on environmental risk factors that may be associated with Parkinson’s disease at ANA 2022.

SPONSORED CONTENT
October 21, 2022
1 min read
Save

FDA will not hold advisory committee meeting to discuss NDA for Friedreich’s ataxia drug

FDA will not hold advisory committee meeting to discuss NDA for Friedreich’s ataxia drug

Reata Pharmaceuticals Inc. announced the FDA does not plan to hold an advisory committee meeting to discuss the company’s new drug application for an investigational therapeutic to treat Friedreich’s ataxia.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails